256
Views
33
CrossRef citations to date
0
Altmetric
Review

Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review

, &
Pages 1151-1166 | Published online: 03 Jul 2018

References

  • W H OAdherence to long-term therapies: evidence for action2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed June 23, 2017
  • van MierloTFournierRInghamMTargeting medication non-adherence behavior in selected autoimmune diseases: a systematic approach to digital health program developmentPLoS One2015106e012936426107637
  • De VeraMAMailmanJGaloJSEconomics of non-adherence to biologic therapies in rheumatoid arthritisCurr Rheumatol Rep2014161146025227187
  • VangeliEBakhshiSBakerAA systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseasesAdv Ther20153211983102826547912
  • WongPKMedication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?Rheumatol Int201636111535154227665289
  • CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Heal20081114447
  • VrijensBDe GeestSHughesDAA new taxonomy for describing and defining adherence to medicationsBr J Clin Pharmacol201273569170522486599
  • López-GonzálezRLeónLLozaERedondoMGarcia de YébenesMJCarmonaLAdherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature reviewClin Exp Rheumatol201533455956925602291
  • de AchavalSSuarez-AlmazorMETreatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosusInt J Clin Rheumatol201053313326
  • Scheiman-ElazaryADuanLShourtCThe rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: a systematic literature review and metaanalysisJ Rheumatol201643351252326879354
  • van den BemtBJZwikkerHEvan den EndeCHMedication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literatureExpert Rev Clin Immunol20128433735122607180
  • ShiLLiuJFonsecaVWalkerPKalsekarAPawaskarMCorrelation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysisHealth Qual Life Outcomes2010819920836888
  • PasmaAvan’t SpijkerAHazesJMBusschbachJJLuimeJJFactors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic reviewSemin Arthritis Rheum2013431182823352247
  • CurtisJRBykerkVPAassiMSchiffMAdherence and persistence with methotrexate in rheumatoid arthritis: a systematic reviewJ Rheumatol201643111997200927803341
  • Costedoat-ChalumeauNPouchotJGuettrot-ImbertGAdherence to treatment in systemic lupus erythematosus patientsBest Pract Res Clin Rheumatol201327332934024238690
  • NguyenTMLa CazeACottrellNWhat are validated self-report adherence scales really measuring?: a systematic reviewBr J Clin Pharmacol201477342744523803249
  • de KlerkEvan der HeijdeDvan der TempelHvan der LindenSDevelopment of a questionnaire to investigate patient compliance with antirheumatic drug therapyJ Rheumatol199926122635264110606375
  • LamWYFrescoPMedication adherence measures: an overviewBiomed Res Int2015201521704726539470
  • SmolenJSLandewéRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateAnn Rheum Dis201473349250924161836
  • GossecLSmolenJSRamiroSEuropean League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 updateAnn Rheum Dis201675349951026644232
  • SmolenJSBraunJDougadosMTreating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceAnn Rheum Dis201473161623749611
  • BertsiasGIoannidisJPBoletisJEULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsAnn Rheum Dis200867219520517504841
  • HorneRWeinmanJHankinsMThe beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medicationPsychol Health1999141124
  • ChuLHKawatkarAAGabrielSEMedication adherence and attrition to biologic treatment in rheumatoid arthritis patientsClin Ther2015373660.e8666.e825618317
  • BonafedeMJohnsonBHTangDHShahNHarrisonDJCollierDHEtanercept-methotrexate combination therapy initiators have greater adherence and persistence than triple therapy initiators with rheumatoid arthritisArthritis Care Res (Hoboken)201567121656166326097194
  • KimGBarnerJCRascatiKRichardsKExamining time to initiation of biologic disease-modifying antirheumatic drugs and medication adherence and persistence among texas medicaid recipients with rheumatoid arthritisClin Ther201638364665426899313
  • KumarKRazaKNightingalePDeterminants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional studyBMC Musculoskelet Disord201516139626714853
  • GadallahMABoulosDNDewedarSGebrelAMoriskyDEAssessment of rheumatoid arthritis patients’ adherence to treatmentAm J Med Sci2015349215115625474222
  • De CuyperEDe GuchtVMaesSVan CampYDe ClerckLSDeterminants of methotrexate adherence in rheumatoid arthritis patientsClin Rheumatol20163551335133926781783
  • SalaffiFCarottiMDi CarloMFarahSGutierrezMAdherence to anti–tumor necrosis factor therapy administered subcutaneously and associated factors in patients with rheumatoid arthritisJCR J Clin Rheumatol201521841942526587852
  • HromadkovaLSoukupTVlcekJQuality of life and drug compliance: their interrelationship in rheumatic patientsJ Eval Clin Pract201521591992426083391
  • Abdul-SattarABAbou El MagdSADeterminants of medication non-adherence in Egyptian patients with systemic lupus erythematosus: Sharkia GovernorateRheumatol Int20153561045105125424491
  • BetegnieALGauchetALehmannAWhy do patients with chronic inflammatory rheumatic diseases discontinue their biologics? an assessment of patients’ adherence using a self-report questionnaireJ Rheumatol201643472473026879361
  • LyuRGovoniMDingQTreatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in GermanyRheumatol Int201636114315326314368
  • MachadoMAMouraCSFerréFBernatskySRahmeEAcurcioF de ATreatment persistence in patients with rheumatoid arthritis and ankylosing spondylitisRev Saude Publica2016505027556964
  • GlintborgBHøjgaardPLund HetlandMImpact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registryRheumatology (Oxford)201655465966826628579
  • HøjgaardPGlintborgBHetlandMLAssociation between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryAnn Rheum Dis201574122130213625063827
  • MorganCMcBethJCordingleyLThe influence of behavioral and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics eraRheumatology (Oxford)201554101780179125972390
  • DiMatteoMRGiordaniPJLepperHSCroghanTWPatient adherence and medical treatment outcomes: a meta-analysisMed Care200240979481112218770
  • SoutoAManeiroJRGómez-ReinoJJRate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databasesRheumatology (Oxford)201655352353426490106
  • BrownMTBussellJKMedication adherence: WHO cares?Mayo Clin Proc201186430431421389250
  • SöderlinMKPeterssonIFGeborekPThe effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drugScand J Rheumatol20124111922118371
  • FagerliKMLieEvan der HeijdeDThe role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD studyAnn Rheum Dis201473113213723291385
  • MichettiPWeinmanJMrowietzUImpact of treatment-related beliefs on medication adherence in immune-mediated inflammatory diseases: results of the Global ALIGN StudyAdv Ther20173419110827854054
  • NotaIDrossaertCHTaalEvan de LaarMAPatients’ considerations in the decision-making process of initiating disease-modifying anti-rheumatic drugsArthritis Care Res (Hoboken)201567795696425504789
  • MartinRWHeadAJRenéJPatient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physicianJ Rheumatol200835461862418278840
  • PayneRAThe epidemiology of polypharmacyClin Med (Lond)201616546546927697812
  • ChapmanRHBennerJSPetrillaAAPredictors of adherence with antihypertensive and lipid-lowering therapyArch Intern Med2005165101147115215911728
  • TavaresNUBertoldiADMengueSSFatores associados à baixa adesão ao tratamento farmacológico de doenças crônicas no Brasil [Factors associated with low adherence to medicine treatment for chronic diseases in Brazil]Rev Saude Publica201650Suppl 210s Portuguese
  • de KlerkEvan der HeijdeDLandewéRvan der TempelHUrquhartJvan der LindenSPatient compliance in rheumatoid arthritis, polymyalgia rheumatica, and goutJ Rheumatol2003301445412508389
  • ManeiroJRSalgadoEGomez-ReinoJJImmunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated inflammatory conditions: systematic review and meta-analysisJAMA Intern Med2013173151416142823797343
  • Garcia-GonzalezARichardsonMGarcia Popa-LisseanuMTreatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosusClin Rheumatol200827788388918185905
  • PasmaASchenkCVTimmanRNon-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the diseaseArthritis Res Ther201517128126449852
  • CliffordSBarberNHorneRUnderstanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns FrameworkJ Psychosom Res2008641414618157998
  • FootHLa CazeAGujralGCottrellNThe necessity–concerns framework predicts adherence to medication in multiple illness conditions: a meta-analysisPatient Educ Couns201699570671726613666
  • NeameRHammondABeliefs about medications: a questionnaire survey of people with rheumatoid arthritisRheumatology (Oxford)200544676276715741193
  • de VriesSTKeersJCVisserRMedication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetesJ Psychosom Res201476213413824439689
  • LarkinATHoffmanCStevensADouglasABloomgardenZDeterminants of adherence to diabetes treatmentJ Diabetes20157686487125565088
  • Andersson SundellKJönssonAKBeliefs about medicines are strongly associated with medicine-use patterns among the general populationInt J Clin Pract201670327728526916721